Announcement of a strategic alliance between Franklin Biolabs and Nordic Cell Therapy Group designed to support cell therapy developers across the full cell therapy lifecycle.

Coverage in BioSpectrum highlighting the Memorandum of Understanding between Nordic Cell Therapy Group and Nucelion Therapeutics, supporting collaboration in advanced cell therapy development.

Featured in Børsen, Denmark’s leading financial newspaper, highlighting the founding of Nordic Cell Therapy Group and its focus on advancing cell therapy programs, consultancy services, and therapeutic innovation.

Memorandum of Understanding with Nucelion Therapeutics to explore collaboration opportunities in cell therapy, focusing on the exchange of expertise and evaluation of joint activities supporting the development and translation of advanced therapy programs.

Collaboration with ClexBio to support the advancement of the VivoSet™ platform, contributing expertise in scalable cell therapy development and CMC strategy as the program progresses toward GMP and clinical application.

Mention in TheRegenReport highlighting Nordic Cell Therapy Group within the broader context of recent developments in the cell therapy field.